EGM will be held on 12.02.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Ltd has called an Extra-Ordinary General Meeting on February 12, 2026, via video conferencing. Two special resolutions are on the agenda: (1) preferential allotment of up to 25,96,935 equity shares at Rs. 89 per share (including Rs. 79 premium), aggregating about Rs. 23.11 crore, to one promoter group entity and 30 non-promoter allottees; and (2) issue of up to 23,60,065 fully convertible warrants at Rs. 89 per warrant to promoter families (Jaju and Kakani groups), exercisable into one equity share each within 18 months with 25% upfront payment. The pricing is fixed as per SEBI ICDR Regulations with January 13, 2026 as the relevant date. On a fully diluted basis, total equity will rise from 75.30 lakh to 1.25 crore shares, with promoter holding dipping marginally from 52.61% to 51.52%. The company stated there is no change in control and no open offer trigger under SEBI Takeover Code.
Existing shareholders will see dilution of about 66% on a fully diluted basis, though promoter stake only drops marginally. The Rs. 23+ crore (plus potential additional warrants conversion) is meant to strengthen the capital base and fund growth — supportive if the deployment is value-accretive, but short-term EPS dilution is likely.